U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C14H20N2O3S
Molecular Weight 296.385
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GLYCYCLAMIDE

SMILES

CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2

InChI

InChIKey=RIGBPMDIGYBTBJ-UHFFFAOYSA-N
InChI=1S/C14H20N2O3S/c1-11-7-9-13(10-8-11)20(18,19)16-14(17)15-12-5-3-2-4-6-12/h7-10,12H,2-6H2,1H3,(H2,15,16,17)

HIDE SMILES / InChI

Molecular Formula C14H20N2O3S
Molecular Weight 296.385
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Glycyclamide (Tolcyclamide) isn a cyclohexyl-containing sulfonylurea compound with antihyperglycemic activity. Tolcyclamide is closely related to tolbutamide, with a cyclohexyl ring in place of the butyl group. It is much less potent than glipizide, being active at a daily dose of 1000 mg.

Originator

Approval Year

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Diaboral

PubMed

Sample Use Guides

In Vivo Use Guide
Daily dose for diabetes treatment is 500-1500 mg
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Record UNII
C40N4EJY68
Record Status Validated (UNII)
Record Version